NOX 5.71% 6.6¢ noxopharm limited

Ann: Veyonda Showing Potential to Prevent Cytokine Storm, page-6

  1. 572 Posts.
    lightbulb Created with Sketch. 347
    Well, this is better than expected. None of the biomarkers in ANY of the 18 patients increased. And this is not including the highest 1800mg dose.

    Given the establish safety profile of Veyonda, the path to commercialisation here could be short.

    But really, better than that is the potential number of lives saved if this translates to clinical outcomes.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.004(5.71%)
Mkt cap ! $19.28M
Open High Low Value Volume
7.6¢ 7.6¢ 6.6¢ $3.396K 49.28K

Buyers (Bids)

No. Vol. Price($)
2 57227 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 11999 1
View Market Depth
Last trade - 10.52am 05/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.